Last quarter (Q ), Evolutionary Genomics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Evolutionary Genomics's net income was $-414.89K. See Evolutionary Genomics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	$ 12.50K	$ 122.69K	$ 114.81K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 98.45K	$ -2.01M	$ 2.88M	$ 2.89M	$ 897.51K	$ 951.61K
Operating Income	$ -2.01M	$ -2.01M	$ -2.88M	$ -2.88M	$ -774.83K	$ -836.80K
Net Non Operating Interest Income Expense	$ 78.90K	$ 79.33K	$ 604.00	-	-	-
Other Income Expense	$ 438.00	-	$ -83.39K	$ 180.56K	$ 13.59K	$ -261.82K
Pretax Income	$ -1.93M	$ -1.93M	$ -2.79M	$ -2.70M	$ -761.23K	$ -1.10M
Tax Provision	$ -406.34K	$ -406.34K	$ -586.73K	$ -987.35K	$ 31.91K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.25M	$ -2.25M	$ -3.08M	$ -2.00M	$ -1.06M	$ -1.34M
Basic EPS	$ -0.35	$ -0.35	$ -0.52	$ -0.34	$ -0.18	$ -0.23
Diluted EPS	$ -0.35	$ -0.35	$ -0.52	$ -0.34	$ -0.18	$ -0.23
Basic Average Shares	$ 25.64M	$ 6.46M	$ 5.88M	$ 5.88M	$ 5.88M	$ 5.88M
Diluted Average Shares	$ 25.64M	$ 6.46M	$ 5.88M	$ 5.88M	$ 5.88M	$ 5.88M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 98.45K	$ -2.01M	$ 2.88M	$ 2.89M	$ 897.51K	$ 951.61K
Net Income From Continuing And Discontinued Operation	$ -1.93M	$ -1.93M	$ -2.79M	$ -1.71M	$ -793.14K	$ -1.10M
Normalized Income	$ -1.06M	-	-	$ -1.83M	$ -803.06K	$ -836.80K
Interest Expense	-	-	-	-	-	-
EBIT	$ -1.94M	$ -1.93M	$ -2.79M	$ -2.88M	$ -774.83K	$ -836.80K
EBITDA	$ -914.32K	$ -913.47K	$ -1.76M	$ -2.47M	$ -734.10K	$ -795.72K

Currency in USD

Evolutionary Genomics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing